MADISON, WI, USA — Nimble Therapeutics, a biotechnology company revolutionizing the discovery and development of peptide therapeutics, today announced their strategic research collaboration with Incyte

MINNEAPOLIS and SALT LAKE CITY, Sept. 8, 2021 /PRNewswire/ — Bio-Techne, a leading supplier of high-quality and innovative tools for life science research, therapeutic manufacturing and clinical diagnostics and Carterra

San Diego & HILDEN, Germany & GERMAN TOWN, Md – (BUSINESS WIRE) — QIAGEN N.V. (NYSE: QGEN) (Frankfurt Prime Standard: QIA) and Verogen today announced

Marcy l’Étoile, France and Mountain View, California – June 29th, 2021 – bioMérieux, a world leader in the field of in vitro diagnostics, and Specific

Madison, WI, USA, & San Diego, CA, USA June 28, 2021 — Nimble Therapeutics and RayzeBio today announced the companies have entered a strategic collaboration

HOLLISTER, Calif., June 24, 2021 (GLOBE NEWSWIRE) — Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the development and production

PORT WASHINGTON, N.Y., June 1, 2021 /PRNewswire/ — Precision NanoSystems (PNI) has been acquired by Danaher Corporation’s Life Sciences platform. PNI is a global leader in technologies and solutions

MARLBOROUGH, Mass., April 15, 2021 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the pricing of its initial

CODEX’s spatial phenotyping capabilities will contribute to HCA investigators’ ability to build comprehensive tissue maps. MARLBOROUGH, Mass. — March 23, 2021 — Akoya Biosciences, Inc., The Spatial

MINNEAPOLIS and AUSTIN, Texas, March 3, 2021  /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic

Cardiff, UK, March 3, 2021 ‒ TrakCel, a leading supplier of cellular orchestration solutions supporting the cell and gene therapy industry, today announces that it has closed

Investment will bring Canada’s first centre of manufacturing excellence of nanomedicine-based RNA vaccines, gene therapies and cell therapies. At project completion early in 2023, the